According to Fortune Business Insights, the global atherectomy devices market size was valued at USD 862.62 million in 2025 and is projected to grow from USD 922.09 million in 2026 to USD 1,571.7 million by 2034, exhibiting a CAGR of 6.89% during the forecast period. The increasing prevalence of cardiovascular diseases and rising demand for minimally invasive vascular procedures are driving the growth of the global market.
The growing incidence of peripheral artery disease (PAD) and coronary artery disease (CAD) is one of the major factors accelerating the demand for atherectomy devices worldwide. Sedentary lifestyles, obesity, diabetes, smoking habits, and aging populations are significantly contributing to vascular disorders, increasing the need for advanced treatment solutions.
Atherectomy devices are widely used to remove plaque deposits from blood vessels, helping restore blood flow and reduce complications associated with arterial blockages. Compared to traditional surgical procedures, atherectomy treatments offer shorter recovery periods, lower risks, and improved patient outcomes, making them increasingly preferred by healthcare providers.
Continuous advancements in medical technology are transforming the atherectomy devices market. Manufacturers are introducing highly advanced devices featuring improved precision, enhanced plaque removal efficiency, and image-guided navigation systems. Technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are helping physicians perform accurate and minimally invasive procedures.
Additionally, the development of low-profile catheters and advanced rotational and orbital atherectomy systems is improving treatment effectiveness for heavily calcified arterial lesions. These innovations are expected to create significant growth opportunities for market players during the forecast period.
Based on application, the peripheral artery disease segment dominates the atherectomy devices market due to the increasing number of PAD patients globally. Atherectomy procedures are commonly used to treat blocked peripheral arteries, especially in elderly patients suffering from diabetes and hypertension.
Meanwhile, the coronary artery disease segment is expected to witness substantial growth owing to the rising number of minimally invasive cardiovascular interventions across hospitals and specialty clinics worldwide.
North America holds the largest share of the global atherectomy devices market due to advanced healthcare infrastructure, increasing healthcare expenditure, and high adoption of innovative cardiovascular technologies. The presence of leading medical device manufacturers and favorable reimbursement policies further support regional market growth.
Europe also represents a significant market owing to rising awareness regarding cardiovascular disorders and increasing adoption of minimally invasive surgical procedures. The Asia-Pacific region is anticipated to witness the fastest growth during the forecast period due to improving healthcare facilities, growing medical tourism, and expanding patient populations in countries such as China and India.
Leading players operating in the atherectomy devices market are focusing on product innovations, partnerships, mergers, and acquisitions to strengthen their market position. Companies are heavily investing in research and development activities to launch safer and more efficient atherectomy technologies.
Some major companies operating in the market include: